Bemethyl (Bemitil / Metaprot)

Synthetic — benzimidazole actoprotector
Evidence Level
Limited
3 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Synthetic benzimidazole 'actoprotector' developed in the 1970s by Vladimir Vinogradov at the S.M. Kirov Military Medical Academy (Leningrad, USSR). Original prototype actoprotector — class definition: enhances physical and mental performance under stress without increasing oxygen consumption (distinguishing from typical stimulants). First given to Soviet cosmonauts and the USSR national athletic team for the 1980 Moscow Olympic Games. Later used by Soviet/Russian armies including the Afghanistan war for soldier performance under hypoxia, hot weather, and prolonged marches. Approved for medicinal drug status in Ukraine, Moldova, and Georgia; available as Antihot dietary supplement in Ukraine. WADA monitoring program 2018 — flagged for documented ergogenic effects. Not FDA-approved.

Studied Dose RUSSIAN/CIS APPROVED: 250-500 mg 1-2×/day for asthenia; courses 3-5 days with 2-3 day breaks. ATHLETIC: 250 mg 2×/day × 5 days. Long half-life — tissue accumulation. WADA monitoring since 2018 — competitive athletes should avoid.
Active Compound Bemethyl (2-(ethylsulfanyl)-1H-benzimidazole hydrobromide; bemitil, metaprot, bemiton, bemactor, antihot, ethylthiobenzimidazole) — synthetic benzimidazole derivative

Benefits

Asthenic disorders (1988 RCT vs piracetam/pyriditol)

1988 asthenic disorders RCT showed bemethyl superiority vs piracetam and pyriditol — 78% improvement at day 10. Russian-language methodology limits Western evidence assessment, but the head-to-head design against active comparators is methodologically meaningful.

Physical performance enhancement (Soviet cosmonauts/athletes)

Documented historical use: Soviet cosmonauts (space program), USSR national athletic team for 1980 Moscow Olympic Games, and Soviet/Russian military personnel. Real-world ergogenic application across high-stress, high-demand contexts — supports the actoprotector class definition.

Hypoxia tolerance and altitude performance

Antihypoxant mechanism — reduces oxygen requirements under stress. Used in Afghanistan war for soldier performance under high-altitude hypoxia and hot weather. Distinguishing from oxygen-consuming stimulants.

Heat tolerance and combined CO/heat protection

Sedov 1991 — combined carbon monoxide and heat resistance enhancement. Occupational stress resistance evidence; relevant to firefighting, military, and industrial exposure contexts.

Liver regeneration support (Gaĭvoronskaia)

Gaĭvoronskaia work documents liver regeneration support — preclinical evidence for hepatic-recovery applications. Mechanism complement to the broader stress-protective profile.

Cognitive performance under stress

Preclinical and clinical evidence for cognitive performance enhancement under stress conditions. Distinguishes from purely physical performance — supports the dual physical/mental positioning of the actoprotector class.

Mechanism of action

1

Mitochondrial protein synthesis enhancement

Bemethyl enhances mitochondrial protein synthesis — supports increased cellular energy capacity under stress. Mechanism distinct from mitochondrial uncoupling or stimulant adrenergic pathways.

2

Antihypoxant — reduced oxygen requirements under stress

Reduces cellular oxygen requirements during stress states. The class-defining actoprotector mechanism — enables performance enhancement without increased oxygen consumption.

3

Antioxidant activity

Antioxidant activity protects tissues from stress-induced oxidative damage — complements the antihypoxant effect.

4

Cumulative tissue accumulation

Resists metabolization and accumulates in tissues (1.38× brain, 1.68× liver in rats over treatment course). Long-lasting effects beyond dosage discontinuation — explains the course-based dosing pattern (3-5 days on, 2-3 days break) used in Russian protocols.

5

Antimutagenic effects

Documented antimutagenic activity — supports the broader stress-protective and tissue-recovery profile beyond pure performance enhancement.

6

Enhancement of other CNS drugs

Enhances effects of nootropic, stimulant, and adaptogen compounds while reducing side effects of antibiotics, immunosuppressants, and tranquilizers. Pharmacological adjuvant profile — relevant to stack contexts.

Clinical trials

1
1988 Asthenic Disorders RCT (Bemethyl vs Piracetam vs Pyriditol)

1988 head-to-head RCT in asthenic disorders. Bemethyl showed 78% improvement at day 10, with superiority vs piracetam and pyriditol. Side effects (pulse lability, sweating, irritability, insomnia) in 11% of users. Russian-language methodology limits Western evidence assessment; head-to-head active-comparator design is methodologically meaningful.

2
Sedov 1991 — Combined CO and Heat Resistance

Sedov 1991 — combined carbon monoxide and heat resistance enhancement evidence. Occupational stress resistance application — relevant to firefighting, military, and industrial exposure contexts.

3
Kwiatkowska 2018 — WADA Monitoring Program PK Study

Kwiatkowska 2018 — WADA detection methods development, prompted by 2018 monitoring program inclusion. Reflects WADA's recognition of the documented ergogenic effects without yet formally prohibiting use. Pharmacokinetic data informing Western detection methods.

Side effects and drug interactions

Common Potential side effects

Pulse lability, irritability, insomnia, sweating reported in 11% of users (1988 trial).
Headache.
GI upset.
WADA MONITORING — athletes warned, not yet prohibited but flagged.
Pregnancy/lactation: avoid.
Long-term safety: Russian/CIS clinical experience supports general safety; Western evaluation limited.
Tissue accumulation may produce sustained effects beyond treatment course.

Important Drug interactions

Nootropic drugs (piracetam): SYNERGISTIC effects — used in Russian combination protocols.
Psychostimulants: SYNERGISTIC enhancement.
Adaptogens (Rhodiola, Eleuthero): synergistic actoprotective effects.
Antibiotics: REDUCES side effects (Russian clinical use).
Immunosuppressants: theoretical reduction of side effects.
Tranquilizers (benzodiazepines): theoretical reduction of side effects.

Frequently asked questions about Bemethyl (Bemitil / Metaprot)

What is Bemethyl (Bemitil / Metaprot)?

Synthetic benzimidazole 'actoprotector' developed in the 1970s by Vladimir Vinogradov at the S.

What does Bemethyl (Bemitil / Metaprot) do?

Bemethyl enhances mitochondrial protein synthesis — supports increased cellular energy capacity under stress. Mechanism distinct from mitochondrial uncoupling or stimulant adrenergic pathways. In clinical research, Bemethyl (Bemitil / Metaprot) has been studied for asthenic disorders (1988 rct vs piracetam/pyriditol), physical performance enhancement (soviet cosmonauts/athletes), hypoxia tolerance and altitude performance.

Who should take Bemethyl (Bemitil / Metaprot)?

Bemethyl (Bemitil / Metaprot) may be most relevant for people interested in energy, athletic performance, cognitive. It has been clinically studied for asthenic disorders (1988 rct vs piracetam/pyriditol), physical performance enhancement (soviet cosmonauts/athletes), hypoxia tolerance and altitude performance. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Bemethyl (Bemitil / Metaprot) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Bemethyl (Bemitil / Metaprot)?

For performance or energy goals, Bemethyl (Bemitil / Metaprot) is typically taken 30-60 minutes before exercise or in the morning. Some people take it with food to reduce GI sensitivity; others prefer empty-stomach timing for faster absorption. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Bemethyl (Bemitil / Metaprot) worth taking?

Bemethyl (Bemitil / Metaprot) has limited clinical evidence (Evidence Level 2/5 on NutraSmarts) — preliminary research suggests potential benefit, but more rigorous trials are needed. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Bemethyl (Bemitil / Metaprot) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Bemethyl (Bemitil / Metaprot)?

The clinically studied dose for Bemethyl (Bemitil / Metaprot) is RUSSIAN/CIS APPROVED: 250-500 mg 1-2×/day for asthenia; courses 3-5 days with 2-3 day breaks. ATHLETIC: 250 mg 2×/day × 5 days. Long half-life — tissue accumulation. WADA monitoring since 2018 — competitive athletes should avoid.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Bemethyl (Bemitil / Metaprot) used for?

Bemethyl (Bemitil / Metaprot) is studied for asthenic disorders (1988 rct vs piracetam/pyriditol), physical performance enhancement (soviet cosmonauts/athletes), hypoxia tolerance and altitude performance. 1988 asthenic disorders RCT showed bemethyl superiority vs piracetam and pyriditol — 78% improvement at day 10.